Home » Topics » Regulatory » Patents

Patents
RSS

Origo Biopharma discloses new TGFBR1 inhibitors

April 26, 2022

Jiangsu Chia Tai Tianqing Pharmaceutical researchers synthesize new AKT inhibitors

April 26, 2022

Shenzhen Salubris Pharmaceuticals presents GLP-1 receptor agonists

April 26, 2022

Duality Biologics divulges new ADCs for cancer

April 26, 2022

BeiGene patents new MAP4K1 inhibitors

April 26, 2022

Yonsei University presents new SLC26A4 inhibitors

April 25, 2022

Chinese researchers identify new anti-claudin18.2 ADCs

April 25, 2022

Gilead Sciences discloses new HIV antivirals

April 25, 2022

Chinese investigators patent new THR-beta agonists

April 25, 2022

BioWorld MedTech Patent Highlights: Week 15

From Current Patent Gazette

April 22, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...